Browsing Category
Medicines for Covid-19 (Monoclonal Antibodies)
2 posts
A Valuable COVID Drug Doesn’t Work against New Variants [ bebtelovimab]
health transformationstrategy institute Joaquim Cardoso MScChief Researcher, Editor and Senior AdvisorJanuary3, 2023 Executive Summary [by the Editor of…
The continued evolution of omicron variants reinforces the need for new therapeutic monoclonal antibodies for Covid-19 – remdesivir, molnupiravir, and nirmatrelvir are efficacious against both BQ.1.1 and XBB in vitro.
continuoustranformation4health research institute and advisory consulting Joaquim Cardoso MSc* Founder, and Chief Researcher & EditorDecember 9, 2022 This is…
